메뉴 건너뛰기




Volumn 137, Issue 4, 2018, Pages 405-407

Cardiovascular Outcomes and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus and Peripheral Artery Disease: A Subanalysis of EMPA-REG OUTCOME

Author keywords

diabetes mellitus peripheral arterial disease; sodium glucose cotransporter 2

Indexed keywords

EMPAGLIFLOZIN; HEMOGLOBIN A1C; PLACEBO; BENZHYDRYL DERIVATIVE; GLUCOSIDE;

EID: 85034212680     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.032031     Document Type: Article
Times cited : (143)

References (4)
  • 2
    • 33745002689 scopus 로고    scopus 로고
    • Peripheral arterial disease and risk of cardiac death in type 2 diabetes: The Fremantle Diabetes Study
    • Norman PE, Davis WA, Bruce DG, Davis TM, Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2006 29 575 580
    • (2006) Diabetes Care , vol.29 , pp. 575-580
    • Norman, P.E.1    Davis, W.A.2    Bruce, D.G.3    Davis, T.M.4
  • 4
    • 85030254073 scopus 로고    scopus 로고
    • Accessed October 16, 2017
    • International Working Group on the Diabetic Foot Definitions and criteria. 2015. www.iwgdf.org/files/2015/website-definitions.pdf. Accessed October 16, 2017
    • (2015) Definitions and Criteria


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.